Cargando…

Interrelations between COVID-19 and other disorders

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasmi, Amin, Peana, Massimiliano, Pivina, Lyudmila, Srinath, Shvetha, Gasmi Benahmed, Asma, Semenova, Yuliya, Menzel, Alain, Dadar, Maryam, Bjørklund, Geir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539/
https://www.ncbi.nlm.nih.gov/pubmed/33333255
http://dx.doi.org/10.1016/j.clim.2020.108651
_version_ 1783642087700299776
author Gasmi, Amin
Peana, Massimiliano
Pivina, Lyudmila
Srinath, Shvetha
Gasmi Benahmed, Asma
Semenova, Yuliya
Menzel, Alain
Dadar, Maryam
Bjørklund, Geir
author_facet Gasmi, Amin
Peana, Massimiliano
Pivina, Lyudmila
Srinath, Shvetha
Gasmi Benahmed, Asma
Semenova, Yuliya
Menzel, Alain
Dadar, Maryam
Bjørklund, Geir
author_sort Gasmi, Amin
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease’s prognosis and how severe the outcome can be expected.
format Online
Article
Text
id pubmed-7833539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78335392021-01-26 Interrelations between COVID-19 and other disorders Gasmi, Amin Peana, Massimiliano Pivina, Lyudmila Srinath, Shvetha Gasmi Benahmed, Asma Semenova, Yuliya Menzel, Alain Dadar, Maryam Bjørklund, Geir Clin Immunol Review Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease’s prognosis and how severe the outcome can be expected. Elsevier Inc. 2021-03 2020-12-14 /pmc/articles/PMC7833539/ /pubmed/33333255 http://dx.doi.org/10.1016/j.clim.2020.108651 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Gasmi, Amin
Peana, Massimiliano
Pivina, Lyudmila
Srinath, Shvetha
Gasmi Benahmed, Asma
Semenova, Yuliya
Menzel, Alain
Dadar, Maryam
Bjørklund, Geir
Interrelations between COVID-19 and other disorders
title Interrelations between COVID-19 and other disorders
title_full Interrelations between COVID-19 and other disorders
title_fullStr Interrelations between COVID-19 and other disorders
title_full_unstemmed Interrelations between COVID-19 and other disorders
title_short Interrelations between COVID-19 and other disorders
title_sort interrelations between covid-19 and other disorders
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833539/
https://www.ncbi.nlm.nih.gov/pubmed/33333255
http://dx.doi.org/10.1016/j.clim.2020.108651
work_keys_str_mv AT gasmiamin interrelationsbetweencovid19andotherdisorders
AT peanamassimiliano interrelationsbetweencovid19andotherdisorders
AT pivinalyudmila interrelationsbetweencovid19andotherdisorders
AT srinathshvetha interrelationsbetweencovid19andotherdisorders
AT gasmibenahmedasma interrelationsbetweencovid19andotherdisorders
AT semenovayuliya interrelationsbetweencovid19andotherdisorders
AT menzelalain interrelationsbetweencovid19andotherdisorders
AT dadarmaryam interrelationsbetweencovid19andotherdisorders
AT bjørklundgeir interrelationsbetweencovid19andotherdisorders